Synthesis and structure–activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis-Reference-Cited by-同舟云学术

Synthesis and structure–activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis

Published:2015-06 Issue: Volume:99 Page:14-35
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Pesce Emanuela,Bellotti Marta^ORCID,Liessi Nara,Guariento Sara,Damonte Gianluca^ORCID,Cichero Elena,Galatini Andrea,Salis Annalisa,Gianotti Ambra,Pedemonte Nicoletta^ORCID,Zegarra-Moran Olga,Fossa Paola,Galietta Luis J.V.,Millo Enrico

Funder

Ministero della Salute

Telethon Foundation

Fondazione Italiana Fibrosi Cistica

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment;Rogan;Chest,2011

2. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies;Fanen;Int. J. Biochem. Cell. Biol.,2014

3. Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in cystic fibrosis;Rivas Caldas;J. Cyst. Fibros,2015

4. New horizons in the treatment of cystic fibrosis;Cuthbert;Br. J. Pharmacol.,2011

5. Enhancing the potency of F508del correction: a multi-layer combinational approach to drug discovery for cystic fibrosis;Kirby;J. Pharmacol. Clin. Toxicol.,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms;European Journal of Medicinal Chemistry;2024-02

2. In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein;Pharmaceuticals;2023-12-08

3. Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays;Pharmaceuticals;2023-09-18

4. The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?;Expert Opinion on Pharmacotherapy;2023-07-03

5. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies;Cells;2022-06-08